Upregulation of transmembrane endothelial junction proteins in human cerebral cavernous malformations

Neurosurgical Focus

Volumn 29, Issue 3, 2010, Pages 1-7

  Burkhardt, Jan Karl ^a   Schmidt, Dörthe ^a,b   Schoenauer, Roman ^a   Brokopp, Chad ^a   Agarkova, Irina ^a   Bozinov, Oliver ^a   Bertalanffy, Helmut ^a   Hoerstrup, Simon P ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b PSI   (Switzerland)

Author keywords

Adherence junction; Cell contacts; Cerebral cavernous malformation; Occludin; Tight junction; VE cadherin

Indexed keywords

CADHERIN; CD31 ANTIGEN; CELL ADHESION MOLECULE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; NOS3 PROTEIN, HUMAN; OCCLUDIN; VASCULAR ENDOTHELIAL CADHERIN;

ADOLESCENT; ADULT; ARTICLE; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMANGIOMA; CELL COMMUNICATION; CELL CULTURE; CELL JUNCTION; COMPARATIVE STUDY; CYTOLOGY; ENDOTHELIUM; ENDOTHELIUM CELL; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TIGHT JUNCTION; UPREGULATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, CD31; BLOTTING, WESTERN; CADHERINS; CELL ADHESION MOLECULES; CELL COMMUNICATION; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM; ENDOTHELIUM, VASCULAR; FEMALE; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HUMANS; INTERCELLULAR JUNCTIONS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; TIGHT JUNCTIONS; UP-REGULATION;

EID: 77956218122     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2010.6.FOCUS10125     Document Type: Article

References (28)

1. Al-Shahi R, Bhattacharya JJ, Currie DG, Papanastassiou V, Ritchie V, Roberts RC, et al: Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke 34:1163-1169, 2003
2. Al-Shahi Salman R, Berg MJ, Morrison L, Awad IA: Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Stroke 39:3222-3230, 2008
3. Bertalanffy H, Benes L, Miyazawa T, Alberti O, Siegel AM, Sure U: Cerebral cavernomas in the adult. Review of the literature and analysis of 72 surgically treated patients. Neurosurg Rev 25:1-55, 2002
4. Chappell PM, Steinberg GK, Marks MP: Clinically documented hemorrhage in cerebral arteriovenous malformations: MR characteristics. Radiology 183:719-724, 1992
5. Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D: Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry 71:188-192, 2001
6. Felbor U, Sure U, Grimm T, Bertalanffy H: Genetics of cerebral cavernous angioma. Zentralbl Neurochir 67:110-116, 2006
7. Gault J, Awad IA, Recksiek P, Shenkar R, Breeze R, Handler M, et al: Cerebral cavernous malformations: somatic mutations in vascular endothelial cells. Neurosurgery 65:138-145, 2009
8. Gross BA, Batjer HH, Awad IA, Bendok BR: Brainstem cavernous malformations. Neurosurgery 64:E805-E818, 2009
9. Guzeloglu-Kayisli O, Amankulor NM, Voorhees J, Luleci G, Lifton RP, Gunel M: KRIT1/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex. Neurosurgery 54:943-949, 2004
10. Hilder TL, Malone MH, Bencharit S, Colicelli J, Haystead TA, Johnson GL, et al: Proteomic identification of the cerebral cavernous malformation signaling complex. J Proteome Res 6:4343-4355, 2007
11. Kiliç T, Pamir MN, Küllü S, Eren F, Ozek MM, Black PM: Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery 46:1179-1192, 2000
12. Kleaveland B, Zheng X, Liu JJ, Blum Y, Tung JJ, Zou Z, et al: Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat Med 15:169-176, 2009 (Erratum in Nat Med 15:584, 2009)
13. Leblanc GG, Golanov E, Awad IA, Young WL: Biology of vascular malformations of the brain. Stroke 40:e694-e702, 2009
14. Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T, et al: Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 73: 1459-1464, 2003
15. Plummer NW, Squire TL, Srinivasan S, Huang E, Zawistowski JS, Matsunami H, et al: Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations. Mamm Genome 17:119-128, 2006
16. Revencu N, Vikkula M: Cerebral cavernous malformation: new molecular and clinical insights. J Med Genet 43:716-721, 2006
17. Rigamonti D, Hadley MN, Drayer BP, Johnson PC, Hoenig-Rigamonti K, Knight JT, et al: Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med 319: 343-347, 1988
18. Robinson JR, Awad IA, Little JR: Natural history of the cavernous angioma. J Neurosurg 75:709-714, 1991
19. Robinson JR Jr, Awad IA, Zhou P, Barna BP, Estes ML: Expression of basement membrane and endothelial cell adhesion molecules in vascular malformations of the brain: preliminary observations and working hypothesis. Neurol Res 17:49-58, 1995
20. Stahl S, Gaetzner S, Voss K, Brackertz B, Schleider E, Sürücü O, et al: Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex. Hum Mutat 29:709-717, 2008
21. Steinberg GK, Chang SD, Gewirtz RJ, Lopez JR: Microsurgical resection of brainstem, thalamic, and basal ganglia angiographically occult vascular malformations. Neurosurgery 46:260-271, 2000
22. Tsukita S, Yamazaki Y, Katsuno T, Tamura A, Tsukita S: Tight junction-based epithelial microenvironment and cell proliferation. Oncogene 27:6930-6938, 2008
23. Tu J, Stoodley MA, Morgan MK, Storer KP: Ultrastructural characteristics of hemorrhagic, nonhemorrhagic, and recurrent cavernous malformations. J Neurosurg 103:903-909, 2005
24. Vestweber D: VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 28:223-232, 2008
25. Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, et al: The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med 15:177-184, 2009 (Erratum in Nat Med 15:462, 2009)
26. Wong JH, Awad IA, Kim JH: Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. Neurosurgery 46:1454-1459, 2000
27. Zhao Y, Tan YZ, Zhou LF, Wang HJ, Mao Y: Morphological observation and in vitro angiogenesis assay of endothelial cells isolated from human cerebral cavernous malformations. Stroke 38:1313-1319, 2007
28. Zhu Y, Wloch A, Wu Q, Peters C, Pagenstecher A, Bertalanffy H, et al: Involvement of PTEN promoter methylation in cerebral cavernous malformations. Stroke 40:820-826, 2009